Navignostics
Company Overview
Navignostics AG is a biotechnology company founded in 2022 as a spin-off from the University of Zurich Bodenmiller Lab. Located in Horgen, Switzerland, they specialize in personalized cancer care by analyzing tumor samples and determining the optimal drug treatments for each patient.
What We Do
We utilize highly multiplex tumor imaging combined with advanced data analytics for spatial single-cell proteomics. Our assays detect dozens of proteins from a single tumor tissue section to identify individual tumor and immune cells and describe cancer-related processes. The results help clinicians find personalized treatment plans, and researchers develop new drugs.
Our technology involves multiplex imaging, laser ablation mass cytometry, automated computational workflows, and the generation of comprehensive, easy-to-understand reports to guide clinical treatment decisions and aid cancer research.
Our Values
We emphasize trust in quality, curiosity for ongoing learning, and growth together as a supportive team to battle cancer.
Careers
Navignostics is growing and often seeks new colleagues who share their values. Open positions are listed on their LinkedIn page.